| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/12/2004 | US20040030156 Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives and their use in the treatment of migraine and pain |
| 02/12/2004 | US20040030138 Process for 8-carboxamido-2,6-methano-3-benzazocines |
| 02/12/2004 | US20040030115 Nucleic acids containing the coding regions of the genes encoding such proteins, vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins; useful for diagnosing and treating disorders related to them |
| 02/12/2004 | US20040030114 Myostatin regulatory region, nucleotide sequence determination and methods for its use |
| 02/12/2004 | US20040030033 New film coating |
| 02/12/2004 | US20040029972 Synergistic mixtuyre of antidepressant and serotonine receptor antagonist; psychological disorders; sexual disorders |
| 02/12/2004 | US20040029963 Use of pamoic acid or one of its derivatives, or one of its analogues , for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates |
| 02/12/2004 | US20040029958 Treatment of neurotic disorders |
| 02/12/2004 | US20040029957 Treatment of neurotic disorders |
| 02/12/2004 | US20040029956 Central nervous system disorders; anxiolytic agents; administering escitalopram |
| 02/12/2004 | US20040029954 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/12/2004 | US20040029953 Use of neuropeptide-y antagonists in treatment of alcoholism |
| 02/12/2004 | US20040029950 Nervous system and psychological disorders |
| 02/12/2004 | US20040029943 Antiallergens; antiinflammatory agents; hypotensive agents; central nervous system disorders |
| 02/12/2004 | US20040029938 Medicaments |
| 02/12/2004 | US20040029937 Benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| 02/12/2004 | US20040029932 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/12/2004 | US20040029929 Aminoadamantane derivatives as therapeutic agents |
| 02/12/2004 | US20040029927 Oral administering of tablet of triprolidine |
| 02/12/2004 | US20040029925 Central nervous system disorders; psychological disorders; gastrointestinal disorders |
| 02/12/2004 | US20040029919 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence |
| 02/12/2004 | US20040029917 Benzosuberonylpiperdine compounds as analgesics |
| 02/12/2004 | US20040029912 Bicyclic derivatives |
| 02/12/2004 | US20040029911 Aza-bridged bicyclic amine derivatives for use as novel cholinergic receptor ligands |
| 02/12/2004 | US20040029909 Heat, sulfurization of the corresponding compound with tetraphosphorus tetrasulfide; Parkinson's disease, sexual disorders |
| 02/12/2004 | US20040029904 Spiro(2H-1benzopyran-2,4'-piperidine) derivates as glycine transport inhibitors |
| 02/12/2004 | US20040029894 Nootropic effect enhancer |
| 02/12/2004 | US20040029884 Cyclization in presence of Lawesson's reagent |
| 02/12/2004 | US20040029883 Beta-amino acid compounds as integrin antagonists |
| 02/12/2004 | US20040029880 Anthranyl amides and their use as medicaments |
| 02/12/2004 | US20040029876 Acylamino cyclopropane derivatives |
| 02/12/2004 | US20040029875 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 02/12/2004 | US20040029873 Antiinflammatory agents; Alzheimer's disease; atherosclerosis; inflammatory bowel diseases; antiarthritic agents |
| 02/12/2004 | US20040029869 Methods and compositions for treating or preventing sleep disturbances and associated illnesses using very low doses of cyclobenzaprine |
| 02/12/2004 | US20040029868 Multiple sclerosis; atherosclerosis; inflamamtory bowel diseases; asthma |
| 02/12/2004 | US20040029866 Polymerase enzyme inhibitors |
| 02/12/2004 | US20040029865 Bis-arylsulfones |
| 02/12/2004 | US20040029862 Alzheimer's disease |
| 02/12/2004 | US20040029854 Nirtic oxide donors based on metallic centres |
| 02/12/2004 | US20040029851 Therapy for oxidation stresses; complex of drug and enzyme mimetics |
| 02/12/2004 | US20040029850 Central nervous system disorders; antidepressants; bipolar disorders; rhematic diseases |
| 02/12/2004 | US20040029849 Methods for increasing the therapeutic response to electroconvulsive therapy |
| 02/12/2004 | US20040029847 Anticancer agents; contraceptives |
| 02/12/2004 | US20040029846 Cushing disease; antidepressant; modulate immunology response |
| 02/12/2004 | US20040029833 6-Mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
| 02/12/2004 | US20040029822 Detecting moderator of human chromosomes; calibration; genetic engineering; screening for nervous system defects in mammals |
| 02/12/2004 | US20040029820 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/12/2004 | US20040029811 N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing such trimeres |
| 02/12/2004 | US20040029803 Binding to apoptosis cells |
| 02/12/2004 | US20040029801 Antiinflammatory agents; immunosuppressants; inflammatory bowel disease; antiarthritic agents; autoimmune diseases; administering drug and immunosuppressant |
| 02/12/2004 | US20040029799 Medicament containing activated antithrombin III |
| 02/12/2004 | US20040029793 Genetic engineering; antibodies; antiinflammatory agents, circulation diseases, anticancer agents, antidiabetic agents, gastrointestinal disorders |
| 02/12/2004 | US20040029281 Carrier vectors through an epithelium with tight junctions |
| 02/12/2004 | US20040029279 The packaging systems are based on the expression of split-helper functions by coinfecting cells with recombinant vectors, such as recombinant poxvirus vectors |
| 02/12/2004 | US20040029247 Regulation of human adenylate cyclase, type iv |
| 02/12/2004 | US20040029227 Prolonging expression of an exogenous gene in a cell transduced with the gene; for treatment of brain disorders like tumours, Alzheimer's disease, Parkinson's disease, lateral amyotrophic sclerosis, neurodegenerative disorders |
| 02/12/2004 | US20040029224 Used for determination of ligands (agonists), preparation of antibodies and antisera, construction of recombinant receptor protein expression systems, development of receptor binding assay systems and screening of pharmaceutical candidates |
| 02/12/2004 | US20040029178 For anti-obesity/appetite enhancing drugs; prolactin inhibitors |
| 02/12/2004 | US20040029150 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/12/2004 | US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders |
| 02/12/2004 | US20040029117 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the DNA |
| 02/12/2004 | US20040028815 Combinatorial synthesis |
| 02/12/2004 | US20040028758 Antioxidant composition and method of preparation thereof |
| 02/12/2004 | US20040028732 Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities |
| 02/12/2004 | US20040028723 Matrix with permeable reservoir containing ergoline compound; diffusion barrier |
| 02/12/2004 | US20040028707 Enhanced pharmacokinetic profile of intradermally delivered substances |
| 02/12/2004 | US20040028706 Neuralgia pain treatment by peripheral administration of a neurotoxin |
| 02/12/2004 | US20040028684 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/12/2004 | US20040028673 Compositions and methods for prevention and treatment of amyloid-beta peptide-related disorders |
| 02/12/2004 | US20040028658 Methods of organ regeneration |
| 02/12/2004 | US20040028619 Antiinflammatory agents; bronchodilator agents; antihistamines; respiratory system disorders |
| 02/12/2004 | US20040028617 Mixture with alcohol carrier; administering to drug nose mucous membrane; side effect reduction |
| 02/12/2004 | US20040028613 Intranasal administering; nervous system disorders |
| 02/12/2004 | DE10234424A1 Benzothiophen-, Benzofuran- und Indolharnstoffe Benzothiophene, benzofuran and Indolharnstoffe |
| 02/12/2004 | DE10233366A1 In 6-Stellung substituierte Indolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel In the 6-position substituted indolinone derivatives, their preparation and their use as medicaments |
| 02/12/2004 | CA2495030A1 Cyclopentanone and cyclopentanone derivatives as potent activators of hsf-1 |
| 02/12/2004 | CA2494408A1 Method and compounds for promoting healing and reducing inflammation |
| 02/12/2004 | CA2494308A1 Methods of use of compounds with preptin function |
| 02/12/2004 | CA2494114A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 02/12/2004 | CA2493795A1 Method of preparing platelet rich plasma |
| 02/12/2004 | CA2493637A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/12/2004 | CA2493593A1 Bicifadine formulation |
| 02/12/2004 | CA2493551A1 Aminoalkyl-substituted aryl compounds and their use as sodium channel blockers |
| 02/12/2004 | CA2493301A1 Sustained release formulations comprising lamotrigine |
| 02/12/2004 | CA2491366A1 Improved transdermal delivery system for the administration of rotigotine |
| 02/12/2004 | CA2397684A1 Mitochondrially targeted antioxidants |
| 02/11/2004 | EP1388541A1 Pyrrolopyrazines as kinase inhibitors |
| 02/11/2004 | EP1388534A2 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors |
| 02/11/2004 | EP1388344A1 Composition comprising Salvia Miltiorrhizae, Ginseng, Borneol for treating heart disease, and cerebrovascular diseases |
| 02/11/2004 | EP1388343A1 Antioxidant composition and method of preparation thereof |
| 02/11/2004 | EP1388342A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 02/11/2004 | EP1388341A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/11/2004 | EP1388283A1 Nonhuman model animal of oligodendrocyte development disability |
| 02/11/2004 | EP1387895A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 02/11/2004 | EP1387889A2 Kinases and phosphatases |
| 02/11/2004 | EP1387888A2 Nucleic acid-associated proteins |
| 02/11/2004 | EP1387886A2 Proteases |
| 02/11/2004 | EP1387845A2 PROCESSES FOR THE SYNTHESIS OF DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO-(2,3-f) QUINOLINE |
| 02/11/2004 | EP1387840A1 3,5-diamino-1,2,4-triazoles as kinase inhibitors |
| 02/11/2004 | EP1387838A1 Cyanoanthranilamide derivatives and the use thereof as medicaments |